MIGLIARI, MARCO
 Distribuzione geografica
Continente #
EU - Europa 8.636
NA - Nord America 269
AS - Asia 105
OC - Oceania 2
AF - Africa 1
Totale 9.013
Nazione #
IT - Italia 8.534
US - Stati Uniti d'America 265
SE - Svezia 48
CN - Cina 43
SG - Singapore 18
DE - Germania 14
IN - India 14
NL - Olanda 10
GB - Regno Unito 9
FI - Finlandia 7
HK - Hong Kong 7
FR - Francia 6
TH - Thailandia 4
VN - Vietnam 4
CA - Canada 3
GR - Grecia 3
IR - Iran 3
JP - Giappone 3
KR - Corea 3
AU - Australia 2
IL - Israele 2
ES - Italia 1
IE - Irlanda 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
PH - Filippine 1
PT - Portogallo 1
RU - Federazione Russa 1
TR - Turchia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 9.013
Città #
Cagliari 8.139
Uta 353
Boardman 41
Nyköping 38
Fairfield 35
Chandler 27
Ashburn 21
Houston 12
Rome 11
Shanghai 11
Pune 10
Singapore 10
Santa Clara 9
Seattle 9
Wilmington 9
Amsterdam 8
Boston 8
New York 8
San Diego 8
Woodbridge 8
Helsinki 7
Cambridge 6
Los Angeles 6
Dong Ket 4
Hefei 4
Hong Kong 4
Menlo Park 4
Munich 4
Romainville 4
Clifton 3
Nakano 3
Peristeri 3
San Cipriano d'Aversa 3
Seoul 3
Toronto 3
Delhi 2
Don Mueang 2
Guangzhou 2
Islington 2
Jiaxing 2
London 2
Naples 2
Olbia 2
Paris 2
Rosà 2
San Francisco 2
San Giorgio a Cremano 2
Sydney 2
Xian 2
Zhengzhou 2
Alexandria 1
Amgaon 1
Ankara 1
Ann Arbor 1
Bilbao 1
Chandigarh 1
Council Bluffs 1
Dongyang 1
Dublin 1
Exeter 1
Frattamaggiore 1
Hamburg 1
Heidelberg 1
Jacksonville 1
Jinhua 1
Luxembourg 1
Manila 1
Moscow 1
Nanjing 1
New Bedfont 1
Norwalk 1
Pisa 1
Piscataway 1
Port-of-spain 1
Portland 1
Pozzuoli 1
Rockville 1
Shenzhen 1
Somerville 1
South Deerfield 1
Stockholm 1
Tabriz 1
Tashkent 1
Tel Aviv 1
Washington 1
Wuhan 1
Totale 8.902
Nome #
Molecular-biology-driven treatment for metastatic colorectal cancer 2.641
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment 1.239
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors 886
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast? 796
The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment 729
New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression 613
Uncovering key targets of success for immunotherapy in pancreatic cancer 596
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus 563
BRCA-mutant pancreatic ductal adenocarcinoma 491
Immune Checkpoint Inhibitors in the Treatment of HCC 489
Totale 9.043
Categoria #
all - tutte 13.295
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.295


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021959 0 0 1 330 197 120 40 64 35 70 49 53
2021/2022900 53 48 3 25 40 82 47 101 51 91 179 180
2022/20232.128 240 297 200 148 169 213 99 97 151 274 157 83
2023/20241.655 69 49 69 92 138 296 300 135 78 82 173 174
2024/20253.401 1.147 1.264 316 349 176 149 0 0 0 0 0 0
Totale 9.043